The UK Medicines and Healthcare products Regulatory Agency is to launch a consultation on changes to the clinical trial legislation intended to streamline the approval and start-up of trials, increase the use of novel study designs, and put the patient at the heart of the trials landscape.
A key aim of the legislative changes will be fostering wider international collaboration and “interoperability” with a view to ensuring...